Eye Dynamics 10KSB Filing Shows Higher Profit Than Previously Estimated.Business Editors TORRANCE, Calif.--(BUSINESS WIRE)--March 23, 2004 Eye Dynamics, Inc. (OTCBB OTCBB See OTC Bulletin Board (OTCBB). :EYDY) filed its 10KSB KSB Kogod School of Business (American University) KSB Kelley School of Business (Indiana University) KSB Kantonsschule Am Brühl St. report on March 22, for calendar year 2003. Net profit after tax was higher than previously estimated due to income tax benefits derived from revaluation Revaluation A calculated adjustment to a country's official exchange rate relative to a chosen baseline. The baseline can be anything from wage rates to the price of gold to a foreign currency. In a fixed exchange rate regime, only a decision by a country's government (i.e. of tax assets. Profit after tax was $1,043,027 on revenues of $3,238,284. Revenues were up 79% over 2002 and profit increased to over $1 million from $151,000 in 2002. Overall expenses for 2003 decreased 6% from prior year levels while sales increased 79%. Therefore, expenses, as a percent of revenue, were only 18% in 2003 as opposed to 34% in 2002. Earnings per share for 2003 were $0.06, and when fully diluted $0.05 per share. This is a substantial increase from $0.01 earnings per share in 2002. The increase in sales came from an expanding base of customers, which now includes, in addition to the traditional ENT ENT ears, nose, and throat (otorhinolaryngology). ENT abbr. ear, nose, and throat ENT ear, nose and throat. ENT Ears, nose & throat; formally, otorhinolaryngology physicians, Neurologists, Internal Medicine and Chiropractors. For 2004, expansion into more medical markets is planned as well as closer cooperation with MedTrak Technologies as they expand their product and market base. MedTrak's product line contributed 53% of Eye Dynamics' sales for 2003. It is our plan to provide MedTrak with additional models to distribute, which will enhance their market penetration. About Eye Dynamics, Inc. Eye Dynamics is in the business of producing and marketing patented proprietary products and other services for the institutional, medical and government markets. The company is a leader in the Video ENG ENG electronystagmography. ENG abbr. electronystagmography ENG enzootic nasal granuloma. medical product market, having invented the Video ENG system and brought it to market in 1994. SafetyScope, the company's latest product, is designed for the "fitness-for-duty" screening of workers. SafetyScope is simple to use, takes only 90 seconds and does not require any bodily fluids like urine-based drug testing. It is based on the manual methods of evaluating eye responses of an individual to detect neurological signs of impairment used by law enforcement throughout the United States. To find out more about Eye Dynamics, Inc. (OTC OTC See: Over-the-counter. OTC See over-the-counter market (OTC). :EYDY), visit our web site at www.EYEDYNAMICS.COM (1) (Computer Output Microfilm) Creating microfilm or microfiche from the computer. A COM machine receives print-image output from the computer either online or via tape or disk and creates a film image of each page. . Safe Harbor Safe Harbor 1. A legal provision to reduce or eliminate liability as long as good faith is demonstrated. 2. A form of shark repellent implemented by a target company acquiring a business that is so poorly regulated that the target itself is less attractive. for Forward Looking Statements This news release includes forward-looking statements that are made pursuant to the "safe harbor" provisions of the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and of 1995. While these statements are made to convey to the public the company's progress, business opportunities and growth prospects, readers are cautioned that such forward-looking statements represent management's opinion. Whereas management believes such representations to be true and accurate based on information and data available to the company at this time, actual results may differ materially from those described. The company's operations and business prospects are always subject to risk and uncertainties. Important factors that may cause actual results to differ are set forth in the company's periodic filings with the U.S. Securities and Exchange Commission. |
|
||||||||||||||

Printer friendly
Cite/link
Email
Feedback
Reader Opinion